S10 Ep143: The New Formula (Abbott Laboratories)
Sep 10, 2026 · 1h 10m
More True Crime podcasts · More History podcasts
Summary
This episode investigates the 2025 infant botulism outbreak linked to By Heart formula, tracing its origins to the company’s rapid rise during the 2022 Abbott-led formula shortage. It details how By Heart’s entry into the market exposed the fragility of an industry dominated by three major corporations, while also revealing prior contamination issues at its own facilities. The narrative shifts to the 2022 Abbott recall, highlighting whistleblower allegations of falsified records and the FDA’s delayed response to unsanitary conditions at the Sturgis plant.
Topics discussed
Introduction: Living with indolent systemic mastocytosis
Sponsor: 2026 Nissan Rogue
Rose Dexter's illness and the infant botulism diagnosis
The origin story of By Heart formula
By Heart's rise and the 2022 formula shortage
The By Heart recall and FDA investigation
Lawsuits and the history of formula industry flaws
Sponsors: BMW and Preserve Gold
The 2022 Abbott Labs Cronobacter outbreak
The national formula shortage and government response
Regulatory failures and the perfect storm of negligence
Sponsor: Swindled Valued Listener Rewards
Whistleblower allegations and internal cover-ups at Abbott
Abbott's financial priorities vs. safety investments
Historical pattern of Abbott misconduct and DOJ probe
Abbott's history of fraud, kickbacks, and settlements
Market dominance, WIC programs, and brand loyalty
Sponsors: BMW, Preserve Gold, and EasyCater
NEC in premature infants and the link to formula
The Gill v. Abbott lawsuit and $495M verdict
Conclusion, DOJ resolution, and show credits
Outro: Mastocytosis segment and skincare sponsor
More from Swindled
Listen ad-free on Castria